Technology Bundle ID
TAB-2719

Real-time RT-PCR Assay for the Detection of Rift Valley Fever Virus in Humans and Livestock

Linked ID
E-187-2013-0
Lead Inventors
Brian Bird (CDC)
Co-Inventors
Stuart Nichol (CDC)
Development Stages
Pre-Clinical (in vitro)
Development Status
In vitro data available
ICs
CDC
A quantitative RT-PCR-based assay has been developed to rapidly detect all known strains of Rift Valley fever virus (RVFV). RVFV infections occur in both humans and livestock animals resulting in significant mortality and economic loss. Upon outbreak, RVFV has been known to cause devastating loss among livestock (primarily sheep and cattle) with outbreaks characterized by sweeping "abortion storms" and elevation newborn animal mortality approaching 100% in affected areas. The CDC-developed assay is capable of detecting and quantifying RVFV infection in both human and veterinary samples.
Commercial Applications
  • Diagnostic assay for the detection of Rift Valley fever virus in human and veterinary samples
  • Research tool to quantitatively measure viral load in laboratory specimens
Competitive Advantages
  • Assay detects positive infections for 33 known variants of Rift Valley fever virus.
  • Easily adaptable to kits for high-throughput screening of a large number of samples at once, useful for ensuring herd-health for example.

Request More Info

Licensing Contact: